Differences in clotting parameters between species for preclinical large animal studies of cardiovascular devices
- 129 Downloads
Several species of domestic animals are used in preclinical studies evaluating the safety and feasibility of medical devices; however, the relevance of animal models to human health is often not clear. The purpose of this study was to compare the clotting parameters of animal models to determine which animals most adequately mimic human clotting parameters. The clotting parameters of the different species were assessed in whole blood by in vitro thromboelastography using the clotting activators, such as tissue factor (extrinsic clotting screening test, EXTEM®) and partial thromboplastin phospholipid (intrinsic clotting screening test, IINTEM®). The measurements were performed using normal blood samples from humans (n = 13), calves (n = 18), goats (n = 56) and pigs (n = 8). Extrinsic clotting time (CT) and the intrinsic CT were significantly prolonged in calves compared to humans (249.9 ± 91.3 and 376.4 ± 124.4 s vs. 63.5 ± 11.8 and 192.5 ± 29.0 s, respectively, p < 0.01). The maximum clot firmness (MCF) in domestic animals (EXTEM®: 77–87 mm, IINTEM®: 66–78 mm) was significantly higher than that of humans (EXTEM®: 59.1 ± 6.0 mm, IINTEM®: 58.8 ± 1.5 mm, p < 0.01), and calves and goats exhibited longer time to MCF (MCF-t) than did humans and pigs (p < 0.01). Our results show that there are relevant differences in the four species’ extrinsic and intrinsic clotting parameters. These cross-comparisons indicate that it is necessary to clarify characteristics of clotting properties in preclinical animal studies.
KeywordsClotting Animals Thromboelastography Medical devices Preclinical study
This work was supported by JSPS KAKENHI Grant Number JP17K10745.
Compliance with ethical standards
Conflict of interest
The authors declare that they have no competing interests.
- 1.U.S. Department of Health and Human Services Food and Drug Administration Center for Devices and Radiological Health DoCDOoDE: Guidance for industry and FDA staff general considerations for animal studies for cardiovascular devices, 2010.Google Scholar
- 13.Tuzun E, Roberts K, Cohn WE, et al. In vivo evaluation of investigation the Heart Ware centrifugal ventricular assist device. Texas Heart Inst J. 2007;34:406–11.Google Scholar